PDF(1017 KB)
Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children
HUANG Tie-Shuan, ZHU Jin-Lan, LI Bing, HU Yan, CHEN Li, LIAO Jian-Xiang
Chinese Journal of Contemporary Pediatrics ›› 2009, Vol. 11 ›› Issue (08) : 653-655.
PDF(1017 KB)
PDF(1017 KB)
Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children
OBJECTIVE: To compare the efficacy of valproic acid (VPA) and lamotrigine as a monotherapy for absence epilepsy in children.MethodsA randomized, open-label design was used. Childhood absence epilepsy was diagnosed based on the presence of typical seizures and video-EEG findings. Eligible patients were randomly treated with VPA or lamotrigine. All patients were followed up for 12 months. RESULTS: Forty-five out of 48 eligible children completed the study. There were 23 children in the VPA group and 22 children in the lamotrigine group. Seventeen children were seizure-free in the VPA group 12 months after treatment. Fifteen out of the 17 children showed normal EEG (no epileptic-formed discharge). Twelve children were seizure-free in the lamotrigine group 12 months after treatment. The proportion showing normal EEG in the camotrigine group (6/22, 27.3%) was significantly lower than that in the VPA group (15/23, 65.2%) (P<0.05). Severe adverse effects were not found in both groups. CONCLUSIONS: Both VPA and lamotrigine are safe and efficacious for treatment of absence seizures in children. VPA appears to be better than lamotrigine in tapering epileptic-formed discharge.［Chin J Contemp Pediatr, 2009, 11 (8):653-655］
［1］Lerman Sagie T, Watemberg N, Kramer U, Shahar E, Mermen P. Absence seizures aggravated by valproic acid［J］. Epilepsia, 2001, 42(7):941-943.
［2］杨少青，廖卫平，何小诗.拉莫三嗪单药治疗各型癫癎的开放性自身对照临床研究［J］.临床神经电生理学杂志, 2005, 4(2)：81-84.
［3］Holmes GL, Frank LM, Sheth RD, Philbrook B, Wooten JD, Vuong A, et al. Lamotrigine monotherapy for newly diagnosed typical absence seizures in children. Epilepsy Res, 2008, 82(2-3):124-132.
［4］Akman CI, Holmes GL. The effect on lamotrigine of EEGs of children and adolescents with epilepsy［J］. Epilepsy Behav, 2003, 4(4) 420-423.
［5］周东，吴欣桐，刘凌，杨天华，洪震.“国际抗癫癎联盟关于单药治疗癫癎发作及癫癎综合征治疗指南”简介［J］.中华神经科杂志, 2007， 40 (3)：207-209.
［6］Biton V, Levisohn P, Hoyler S, Vuong A, Hammer AE. Lamotrigine versus valproate monotherapy—associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, doubleblind clinical trial［J］. J Child Neurol, 2003, 18(2):133-139.
［7］Morrell MJ, Hayes FJ, Sluss PM, Adams JM, Bhatt M, Ozkara C, et al. Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine［J］. Ann Neurol, 2008, 64(2):200-211.
［8］Guberman AH, Besag FM, Brodie MJ, Dooley JM, Duchowny MS, Pellock JM, et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children［J］. Epilepsia, 1999, 40(7):985-991.
［9］黄静，任榕娜，陈新民，叶礼燕.抗癫癎药妥泰对幼鼠肝毒性的实验研究［J］.中国当代儿科杂志, 2007, 9(1):54-58.
［10］陈英才，司凯英，高韦娟，王承，纪淑萍，郝月，等.丙戊酸治疗癫癎儿童个体化用药血药浓度监测及临床应用研究［J］.中国当代儿科杂志, 2001, 3(3):330-332.
［11］张坤，王丽，卢炜.癫癎儿童拉莫三嗪的群体药代动力学研究［J］.中国当代儿科杂志, 2008, 10（2）：105-109.
